Elevated levels of tau and phoshorylated tau are recognized hallmarks in the CSF supported diagnosis of Alzheimer’s disease (Kapaki et al., 2007; Snider et al., 2009; Hertze et al., 2010; Scheurich et al. 2010; van Harten et al., 2011). Here, MAPT is linked to Alzheimer disease.